Extended-Spectrum Beta-Lactamases in Clinical Isolates of Klebsiella pneumoniae from Zagreb, Croatia

REFERENCES

• Petit A, Sirot DL, Chanal CM, et al. Novel plasmid mediated beta-lactamase in clinical isolates of Klebsiella pneu-moniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrob Agents Chemother 1988; 32: 626–630.
   PubMed Web of Science ®Google Scholar
• WU SW, Dornbush K, Norgren M, Kronvall G. Extended spectrum beta-lactamase from Klebsiella oxytoca, not belong-ing to the TEM or SHV family. J Antimicrob Chemother 1992; 30: 3–16.
   PubMed Web of Science ®Google Scholar
• Legrand P, Fournier G, Sure A, et al. Detection of extended broad-spectrum beta-lactamases in Entero-bacteriaceae in four French hospitals. Eur J Clin Microbiol Infect Dis 1989; 8: 527–529.
   PubMed Web of Science ®Google Scholar
• Vatoupoulos AC, Phillipon A, Tzouvelekis LS, Komninou Z, Legakis NJ. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumo-niae and Escherichia coli in Greece. J Antimicrob Chemother 1990; 26: 635–648.
   PubMed Web of Science ®Google Scholar
• Katsanis G, Jacoby G. The frequency of extended-spec-trum beta-lactamases in isolates of Klebsiella pneumoniae. J Antimicrob Chemother 1992; 29: 345–353.
   PubMed Web of Science ®Google Scholar
• Payne DJ, Amyes SGB. Transferable resistance to extended-spectrum beta-lactams: a major threat or a minor inconvenience? J Antimicrob Chemother 1991; 27: 255–261.
   PubMed Web of Science ®Google Scholar
• Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1991; 35: 1697–1704.
   PubMed Web of Science ®Google Scholar
• Jones RN, Barry AA, Gavan TL, Washington JA. Susceptibility tests: microdilution and macrodilution broth pro-cedures. In: Lennette EH, Ed. Manual of Clinical Microbiology. 4th ed. Washington DC: American Society for Microbiology, 1985: 972–977.
   Google Scholar
• Palfreyman JM. Klebsiella serotyping by counter-current immunoelectrophoresis. J Hygiene 1978; 81: 219–225.
   PubMedGoogle Scholar
• Power EGM. RAPD typing in microbiology—a technical review. J Hospit Infect 1996; 34: 247–256.
   PubMed Web of Science ®Google Scholar
• Elwell LP, Falkow S. The characterization of R plasmids and the detection of plasmid-specified genes. In: Lorian Antibiotics in Laboratory Medicine. 2nd ed. Baltimore: Williams & Wilkins, 1986: 683–721.
   Google Scholar
• Shannon K, King A, Phillips I. Beta-lactamases with high activity against imipenem and Sch 34343 from Aeromonas hydrophila. J Antimicrob Chemother 1986; 17: 45–50.
   PubMed Web of Science ®Google Scholar
• Perret CJ. Iodometric assay of penicillinase. Nature 1954; 174: 1012–1013.
   PubMed Web of Science ®Google Scholar
• Birnboim HC, Doly J. A rapid alkaline extraction proce-dure for screening recombinant plasmid DNA. Nucleic Acid Res 1979; 7: 1513–23.
   PubMed Web of Science ®Google Scholar
• Stapleton P, Wu P-J, King A, Shannon K, French G, Philips I. Incidence and mechanism of resistance to combina-tion of amoxicillin with clavulanic acid in Escherichia coli. Antimicrob Agents Chemother 1995; 39: 2478–2483.
   PubMed Web of Science ®Google Scholar
• Knothe K, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 35–37.
   PubMedGoogle Scholar
• Buisson CB, Legrand P, Philippon A, Montravers F, Ansquer A, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987; 8: 302–306.
   Google Scholar
• Sirot D, Sirot J, Labia R, et al. Transferable resistance to third generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. J Antimicrob Chemother 1987; 20: 323–334.
   PubMed Web of Science ®Google Scholar
• Spencer RC, Wheat PF, Winstanley TG, Cox DM, Plested SJ. Novel beta-lactamase in a clinical isolate of Klebsiella pneumoniae conferring unusual resistance to beta-lactam antibiotics. J Antimicrob Chemother 1987; 20: 919–921.
   PubMed Web of Science ®Google Scholar
• Vuye A, Verschraegen G, Claeys G. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime. Antimicrob Agents Chemother 1989; 33: 757–761.
   PubMed Web of Science ®Google Scholar
• Gutmann I, Ferre B, Goldstein F W, et al. SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad spec-trum cephalosporins and monobactams. Antimicrob Agents Chemother 1989; 33: 951–956.
   PubMed Web of Science ®Google Scholar
• Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989; 33: 1451–1456.
   PubMed Web of Science ®Google Scholar
• Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985; 28: 302–307.
   PubMed Web of Science ®Google Scholar
• Casellas JM, Goldberg M. Incidence of strains produc-ing extended spectrum beta-lactamases. Infection 1989; 17 (6): 88–90.
   PubMedGoogle Scholar
• Podbielski A, Schonling J, Melzer B, Warnatz K, Leutsch HG. Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae. J Gen Microbiol 1991; 137: 569–578.
   PubMedGoogle Scholar
• Xiang X, Shannon K, French G. Mechanisms and sta-bility of hyperproduction of the extended-spectrum beta-lacta-mase SHV-5 in Klebsiella pneumoniae. J Antimicrob Chemother 1997; 40: 525–532.
   PubMed Web of Science ®Google Scholar
• French GL, Shannon KP, Simmons N. Hospital out-break of Klebsiella pneumoniae resistant to broad spectrum cephalosporins and beta-lactam beta-lactamase inhibitor com-binations by hyperproduction of SHV-5 beta-lactamase. J Clin Microbiol 1996; 34 (2): 358–363.
   PubMed Web of Science ®Google Scholar